Search results
Grateful Dead Drummer Bill Kreutzmann’s Former Home in California Can Be Yours for $4 Million
Robb Report· 2 days agoThe incredible setting allows for panoramic views of the Pacific Ocean and Mendocino Village. The...
A ‘scared’ Biden aide sounds an alarm
Semafor· 11 hours agoTop White House economist Jared Bernstein said Biden “makes decisions on everything from student debt relief to 301 tariffs to housing policy” and...
Justin Bieber performs greatest hits at Anant Ambani-Radhika Merchant’s sangeet ceremony, vibes with...
Indian Express· 2 hours agoOne of the biggest highlights of the evening was a live private concert by Justin Beiber. The...
Dupixent “addresses current gap” in COPD biologics landscape
Pharmaceutical Technology· 18 hours agoNawab said: “The approval is set to improve the treatment landscape for COPD and offer patients a...
Virat Kohli's Reaction As Fan Climbs On Tree To See T20 World Cup Victory Parade Is All Of Us |...
NDTV· 22 hours agoThere was a party atmosphere in Mumbai as thousands gathered on the streets to witness the Indian...
Chorus grows for angel tax repeal; policy push for EVs
The Economic Times· 18 hours agoStartup Inc’s calls to do away with angel tax have found supportfrom the government. Ahead of the...
Discover The Top 10 Exciting Activities To Do In Delhi This Weekend
Latest India News· 3 days agoDelhi, the vibrant heart of India, is like a living thing. Behind its famous landmarks and bustling...
WWE Money in the Bank 2024 Predictions: Damien Priest vs Seth Rollins and Full Match Card
Pinkvilla· 15 hours agoMoney in the Bank 2024 will be the 12th edition of the Money in the Bank series. MITB is one of the
Pressure on diagnostics industry will continue for another five years : A Velumani, Thyrocare Tech
The Economic Times· 21 hours agoMany hospitals took diagnostics as a core business. Just a holistic view coming in because clearly ...
Emcure Pharma IPO Day 2: Issue subscribed 2x; NIIs lead from the front
CNBC Awaaz· 2 days agoBrokerages have positively viewed Emcure Pharma's IPO, considering the public offer fairly priced...